Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-Feb-20 4:15 PM View:  | Radius Health, Inc. (RDUS) | 26-Feb-20 | Market Sale | 1,256 | $17.93 | $22,523.80 | (4%) 35.0K to 33.74K | (2%) |
| 24-Feb-20 6:00 PM View: | Radius Health, Inc. (RDUS) | 20-Feb-20 | Grant | 20,000 | -- | -- | 133% 15.0K to 35.0K | |
| 26-Feb-19 10:00 PM View: | Radius Health, Inc. (RDUS) | 22-Feb-19 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K | |
| 30-Nov-15 9:51 AM View: | Immunogen Inc. (IMGN) | 27-Nov-15 | Market Sale (Planned) | 5,170 | $14.00 | $72,380.00 | (16%) 32.26K to 27.09K | 50% |
| 02-Dec-14 10:25 AM View: | Immunogen Inc. (IMGN) | 28-Nov-14 | Market Sale | 5,240 | $10.40 | $54,496.00 | (14%) 37.5K to 32.26K | 32% |
| 27-Feb-14 9:53 AM View: | Immunogen Inc. (IMGN) | 26-Feb-14 | Option Exercise | 6,936 | $11.93 | $82,746.50 | 18% 37.5K to 44.44K | |
| 27-Feb-14 9:53 AM View: | Immunogen Inc. (IMGN) | 26-Feb-14 | Market Option Sale | 6,936 | $17.35 | $120,333.00 | (16%) 44.44K to 37.5K | 59% |
| 24-Feb-14 2:20 PM View: | Immunogen Inc. (IMGN) | 20-Feb-14 | Option Exercise | 13,672 | $11.93 | $163,107.00 | 36% 37.5K to 51.17K | |
| 24-Feb-14 2:20 PM View: | Immunogen Inc. (IMGN) | 20-Feb-14 | Market Option Sale | 13,672 | $17.10 | $233,737.00 | (27%) 51.17K to 37.5K | 59% |
| 23-Jan-14 11:26 AM View: | Immunogen Inc. (IMGN) | 22-Jan-14 | Option Exercise | 1,603 | $11.93 | $19,123.80 | 4% 37.5K to 39.1K | |
| 23-Jan-14 11:26 AM View: | Immunogen Inc. (IMGN) | 22-Jan-14 | Market Option Sale | 1,603 | $17.00 | $27,257.40 | (4%) 39.1K to 37.5K | 59% |
| 23-Jan-14 11:26 AM View: | Immunogen Inc. (IMGN) | 21-Jan-14 | Option Exercise | 5,535 | $11.93 | $66,032.60 | 15% 37.5K to 43.03K | |
| 23-Jan-14 11:26 AM View: | Immunogen Inc. (IMGN) | 21-Jan-14 | Market Option Sale | 5,535 | $17.00 | $94,095.00 | (13%) 43.03K to 37.5K | 58% |
| 27-Nov-13 1:23 PM View: | Immunogen Inc. (IMGN) | 26-Nov-13 | Market Sale | 12,500 | $13.75 | $171,862.00 | (25%) 50.0K to 37.5K | 49% |
| 05-Sep-12 4:47 PM View: | Allos Therapeutics, Inc. (ALTH) | 04-Sep-12 | Disposition (change in control) | 655,031 | $1.82 | $1,192,160.00 | (100%) 655.03K to 0 | (< 1%) |
| 30-Apr-12 4:58 PM View: | Allos Therapeutics, Inc. (ALTH) | 27-Apr-12 | Market Sale (Planned) | 7,970 | $1.81 | $14,426.50 | (1%) 673.29K to 665.32K | (< 1%) |
| 01-Mar-12 6:13 PM View: | Allos Therapeutics, Inc. (ALTH) | 29-Feb-12 | Market Sale (Planned) | 10,155 | $1.52 | $15,478.30 | (1%) 683.45K to 673.29K | 2% |
| 01-Mar-12 6:13 PM View: | Allos Therapeutics, Inc. (ALTH) | 28-Feb-12 | Grant | 241,848 | -- | -- | 55% 441.6K to 683.45K | |
| 17-Nov-11 5:06 PM View: | Allos Therapeutics, Inc. (ALTH) | 15-Nov-11 | Market Sale (Planned) | 17,829 | $1.44 | $25,723.70 | (4%) 459.43K to 441.6K | |
| 29-Apr-11 4:43 PM View: | Allos Therapeutics, Inc. (ALTH) | 27-Apr-11 | Market Sale (Planned) | 9,800 | $2.84 | $27,825.10 | (2%) 469.23K to 459.43K | (3%) |
| 02-Mar-11 5:08 PM View: | Allos Therapeutics, Inc. (ALTH) | 28-Feb-11 | Grant | 185,851 | -- | -- | 66% 283.38K to 469.23K | |
| 22-Oct-10 5:19 PM View: | Allos Therapeutics, Inc. (ALTH) | 20-Oct-10 | Grant | 173,378 | -- | -- | 158% 110.0K to 283.38K |